This has the potential to improve the diagnostic toolbox for malaria, SLE and Alzheimer’s disease, in which susceptibility or severity is correlated to low levels of CR1 on RBCs. The gene discussed is CR1; the disease is early-onset autosomal dominant Alzheimer disease.